Handelsavisen
prelaunch
Companies Healthcare ITOR.PK
IT
ITOR.PK OTC Healthcare Facilities & Services

Redox International Group Corp

$3,55
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
-226,3 %
ROE
14,5 %
Net margin
-226,3 %
Debt / equity
-0,36
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Redox International Group Corp is a biotechnology company that operates within the healthcare facilities and services industry, primarily generating revenue through its healthcare services and equipment offerings.

Business. Redox International Group Corp (ITOR.PK) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in the United States, the company is listed on the OTC market under the ticker symbol ITOR.PK. Specific details regarding operating segments and geographic presence are not disclosed in the available data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityBiotechnology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
14,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning ITOR.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to ITOR.PK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Redox International Group Corp (ITOR.PK) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in the United States, the company is listed on the OTC market under the ticker symbol ITOR.PK. Specific details regarding operating segments and geographic presence are not disclosed in the available data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityBiotechnology
    AI synthesis
    GENERATED

    Redox International Group Corp has a highly leveraged capital structure, with total liabilities of $30,480 million and total equity of -$25,010 million, resulting in a negative debt-to-equity ratio of -0.36. The company's liquidity position is weak, as evidenced by a current ratio of 0.06, indicating that it has only $0.06 in current assets for every $1 of current liabilities. The operating cash flow of -$16,780 million further highlights the company's cash flow challenges, which could limit its ability to meet short-term obligations.

    Profitability metrics are severely negative, with a net income of -$3,620 million and an operating income of -$3,620 million, indicating that the company is not generating positive earnings from its core operations. The return on equity of 14.47% is misleading due to the negative equity base, and the return on assets of -6.61% suggests that the company is not effectively utilizing its assets to generate profit. These figures are well below the industry median for profitability metrics, which typically show positive returns for companies in the healthcare services and equipment sector.

    The company's revenue of $1,600 million is relatively small compared to its liabilities and equity, and there is no detailed breakdown of revenue by segment or geography in the provided data. This lack of segmentation makes it difficult to assess the company's exposure to different markets or product lines. However, the negative equity and high debt levels suggest that the company may be heavily reliant on a few key markets or products, which could increase its vulnerability to market fluctuations.

    The company's growth trajectory is uncertain, as there is no clear indication of revenue growth in the provided data. The negative operating cash flow and net income suggest that the company is not in a position to sustain growth without external financing. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the key flag of negative net cash after subtracting total debt highlights the company's financial instability. The dilution potential is low, but the company may need to issue additional shares to raise capital, which could dilute existing shareholders' equity.

    Recent events and filings have not been provided in the input data, so it is not possible to assess the company's recent performance or strategic initiatives. However, the financial snapshot suggests that the company is facing significant financial challenges that may require restructuring or additional financing to address.

    The company's risk profile is dominated by liquidity and solvency concerns, with a negative equity position and high debt levels. The risk assessment indicates a medium liquidity risk, which is consistent with the company's weak current ratio and negative operating cash flow. The credit risk is also high due to the company's inability to generate positive cash flow and its reliance on debt financing. The dilution risk is currently low, but the company may need to issue additional shares to raise capital, which could increase the dilution risk in the future.

    Key takeaways
    • Redox International Group Corp has a highly leveraged capital structure with a negative debt-to-equity ratio of -0.36.
    • The company is not generating positive earnings, with a net income and operating income of -$3,620 million.
    • The company's liquidity position is weak, as indicated by a current ratio of 0.06 and a negative operating cash flow of -$16,780 million.
    • The company's return on equity is 14.47%, but this is misleading due to the negative equity base.
    • The company's financial stability is at risk due to its high debt levels and negative equity position.
    • The company may need to issue additional shares to raise capital, which could dilute existing shareholders' equity.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation FY

    Market price
    $3,55
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    -$25.0k
    Net cash
    -$9.0k
    Current ratio
    0.1
    Debt / equity
    -0.4
    ROA
    -66.1%
    ROE
    14.5%
    Cash conversion
    464.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-226,3 %Bottom quartile
    Net Margin-226,3 %Bottom quartile
    ROE14,5 %Above P75
    D/E-0,36Best in class
    Cash Conv4,64Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • Redox International Group Corp Market data — financials · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    ITOR.PKCanonical
    OTC · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage